Quality Assurance is a vital concern of Antellis and constitutes the way of revealing transparency, reliability and traceability of analyses performed to establish a confidence relationship between Antellis and sponsors. A Quality Management System has been built according to ISO 17025, BPL and BPF guidelines. Antellis is periodically inspected by sponsors.
For Antellis Quality Assurance is:
  • A Quality Managment System organised according to NF EN ISO/CEI 17025:2005, GLP (OECD Principles of Good Laboratory Practices) and GMP.
  • An independant Quality Assurance unit.
  • Inspections of study plans, raw data, final reports.
  • A shared quality comitment.
Antellis has been successful inspected (QMS and ICP-MS analysis) by US FDA according to cGMP in May 2013.